International Conferences on Cardio Metabolic Diseases

Important dates

1. 18 Feb

   Abstract / full paper deadline

   In 95 days

2. 22–23 Mar

   Conference

   Sydney, Australia

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

This international meeting aims to advance understanding of cardio metabolic diseases through multidisciplinary collaboration and knowledge sharing. Researchers, physicians, and public health officials will present their work on a range of topics from metabolic syndrome to cardiovascular risk assessment. Attendees will have the chance to present their research through an array of formats, including discussions, poster sessions, and interactive panels. Emphasis will be on data-driven insights that can directly impact clinical outcomes and population health. Participants are encouraged to submit original research and abstracts to facilitate dialogue and explore new treatment strategies. Further details regarding registration and submission protocols will be available on the conference’s dedicated webpage, ensuring straightforward access for all interested parties.

Topics and scope

• Advanced Cardiac Imaging and Diagnostics
• Heart Failure and Cardiomyopathy
• Coronary Artery Disease and Interventional Cardiology
• Arrhythmias and Electrophysiology
• Stroke and Cerebrovascular Disorders
• Pediatric Cardiology and Metabolic Health
• Geriatric Cardiology and Healthy Aging
• Inflammation and Cardiometabolic Diseases
• Genetics and Genomics in Cardiometabolic Medicine
• Gut Microbiome and Metabolic Disorders
• Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolism
• Insulin Resistance and Glucose Regulation
• Novel Drug Development for Cardiometabolic Diseases
• Pharmacological Advances in Diabetes Care
• Cardiometabolic Risk Assessment and Prediction Models
• Population Health and Epidemiology
• Community-Based Prevention Programs
• Health Policy and Healthcare Systems
• Telemedicine and Remote Patient Monitoring
• Wearable Technologies for Cardiometabolic Health
• Big Data Analytics in Cardiovascular Medicine
• Machine Learning Applications in Disease Prediction
• Artificial Intelligence in Clinical Decision Support
• Rehabilitation and Secondary Prevention
• Physical Activity and Exercise Interventions
• Nutraceuticals and Functional Foods
• Sleep Disorders and Cardiometabolic Health
• Mental Health and Cardiometabolic Disease Burden
• Women's Heart Health and Pregnancy-Related Metabolic Disorders
• Global Challenges in Cardiometabolic Disease Management
• Emerging Biomarkers and Precision Diagnostics
• Regenerative Medicine and Stem Cell Therapy
• Clinical Practice Guidelines and Evidence-Based Care
• Healthcare Innovation and Digital Transformation
• Sustainable Healthcare Approaches for Chronic Diseases
• Mechanisms of insulin resistance and metabolic syndrome
• Obesity and its impact on cardiovascular health
• Role of nutrition and diet in managing cardiometabolic diseases
• Exercise interventions and lifestyle modifications
• Pharmacological advancements and therapeutic approaches
• The impact of genetics and epigenetics on disease susceptibility
• Psychosocial factors influencing disease progression and management
• Health disparities and access to care in diverse populations
• Innovations in technology for disease management and prevention

Call for papers

Abstracts are due by 18 February 2027. Submission details are on the official website.